Skip to main content
. 2013 May 27;6:585–591. doi: 10.2147/OTT.S44406

Table 2.

Response for patients treated with Nab-PTX and DDP

Response Number (%) 95% confidence interval
Complete response
Partial response 20 (60.6) 48.5–81.8
Stable disease 9 (27.3) 12.1–45.4
Progressive disease 4 (12.1) 3.0–30.3
Objective response rate 20 (60.6) 48.5–81.8
Disease control rate 29 (87.9) 69.7–97.0

Abbreviations: DDP, cisplatin; Nab-PTX, nanoparticle albumin-bound paclitaxel.